Microsoft Excel LibreOffice Calc

Eli Lilly & Co. (LLY)


Liquidity Analysis

Difficulty: Beginner


Ratios (Summary)

Eli Lilly & Co., liquidity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Current ratio 1.73 1.32 1.37 1.53 1.09
Quick ratio 1.20 0.91 0.98 1.04 0.77
Cash ratio 0.68 0.55 0.55 0.54 0.43

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).

Ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Eli Lilly & Co.’s current ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Eli Lilly & Co.’s quick ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Eli Lilly & Co.’s cash ratio improved from 2016 to 2017 and from 2017 to 2018.

Current Ratio

Eli Lilly & Co., current ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in thousands)
Current assets 20,549,600  19,202,100  15,101,400  12,573,600  12,179,800 
Current liabilities 11,888,100  14,535,900  10,986,600  8,229,600  11,207,500 
Ratio
Current ratio1 1.73 1.32 1.37 1.53 1.09
Benchmarks
Current Ratio, Competitors
Abbott Laboratories 1.62 2.26 4.02 1.54 1.45
AbbVie Inc. 0.98 1.28 1.65 1.50 1.41
Allergan PLC 1.13 1.16 2.27 1.03 1.37
Amgen Inc. 2.79 5.49 4.11 4.44 4.95
Biogen Inc. 2.32 2.34 2.55 2.60 2.11
Bristol-Myers Squibb Co. 1.61 1.55 1.55 1.30 1.73
Celgene Corp. 2.23 4.99 3.67 4.77 4.60
Gilead Sciences Inc. 3.38 2.74 2.22 2.50 3.07
Johnson & Johnson 1.47 1.41 2.47 2.17 2.36
Merck & Co. Inc. 1.17 1.33 1.78 1.55 1.77
Pfizer Inc. 1.57 1.35 1.25 1.49 2.67
Regeneron Pharmaceuticals Inc. 4.47 3.82 2.56 3.59 3.31
Current Ratio, Sector
Pharmaceuticals & Biotechnology 1.70 1.82 2.14 1.92 2.19
Current Ratio, Industry
Health Care 1.52 1.64 1.83 1.73 1.98

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).

2018 Calculations

1 Current ratio = Current assets ÷ Current liabilities
= 20,549,600 ÷ 11,888,100 = 1.73

Ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Eli Lilly & Co.’s current ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.

Quick Ratio

Eli Lilly & Co., quick ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in thousands)
Cash and cash equivalents 7,998,200  6,536,200  4,582,100  3,666,400  3,871,600 
Short-term investments 88,200  1,497,900  1,456,500  785,400  955,400 
Accounts receivable, net of allowances 5,246,500  4,546,300  4,029,400  3,513,000  3,234,600 
Other receivables 958,400  715,900  736,900  558,600  566,700 
Total quick assets 14,291,300  13,296,300  10,804,900  8,523,400  8,628,300 
Current liabilities 11,888,100  14,535,900  10,986,600  8,229,600  11,207,500 
Ratio
Quick ratio1 1.20 0.91 0.98 1.04 0.77
Benchmarks
Quick Ratio, Competitors
Abbott Laboratories 1.03 1.67 3.31 1.04 0.76
AbbVie Inc. 0.78 0.89 1.14 1.21 1.06
Allergan PLC 0.83 0.95 2.00 0.42 0.52
Amgen Inc. 2.44 4.98 3.68 3.97 4.22
Biogen Inc. 1.83 1.78 1.94 1.93 1.54
Bristol-Myers Squibb Co. 1.37 1.30 1.27 1.05 1.26
Celgene Corp. 2.00 4.67 3.24 4.05 4.13
Gilead Sciences Inc. 3.15 2.52 1.78 2.07 2.56
Johnson & Johnson 1.08 1.04 2.04 1.77 1.76
Merck & Co. Inc. 0.72 0.83 1.24 1.04 1.19
Pfizer Inc. 0.84 0.93 0.84 1.07 2.07
Regeneron Pharmaceuticals Inc. 3.50 2.98 2.13 3.10 2.93
Quick Ratio, Sector
Pharmaceuticals & Biotechnology 1.27 1.42 1.69 1.48 1.63
Quick Ratio, Industry
Health Care 1.13 1.29 1.44 1.33 1.48

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).

2018 Calculations

1 Quick ratio = Total quick assets ÷ Current liabilities
= 14,291,300 ÷ 11,888,100 = 1.20

Ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Eli Lilly & Co.’s quick ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.

Cash Ratio

Eli Lilly & Co., cash ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in thousands)
Cash and cash equivalents 7,998,200  6,536,200  4,582,100  3,666,400  3,871,600 
Short-term investments 88,200  1,497,900  1,456,500  785,400  955,400 
Total cash assets 8,086,400  8,034,100  6,038,600  4,451,800  4,827,000 
Current liabilities 11,888,100  14,535,900  10,986,600  8,229,600  11,207,500 
Ratio
Cash ratio1 0.68 0.55 0.55 0.54 0.43
Benchmarks
Cash Ratio, Competitors
Abbott Laboratories 0.45 1.08 2.82 0.67 0.42
AbbVie Inc. 0.47 0.59 0.66 0.77 0.73
Allergan PLC 0.33 0.65 1.68 0.13 0.05
Amgen Inc. 2.17 4.62 3.40 3.62 3.86
Biogen Inc. 1.07 1.10 1.43 1.33 0.83
Bristol-Myers Squibb Co. 0.83 0.71 0.72 0.53 0.88
Celgene Corp. 1.49 4.03 2.69 3.33 3.57
Gilead Sciences Inc. 2.84 2.19 1.29 1.48 1.76
Johnson & Johnson 0.63 0.60 1.59 1.38 1.32
Merck & Co. Inc. 0.40 0.46 0.83 0.70 0.84
Pfizer Inc. 0.59 0.66 0.57 0.79 1.67
Regeneron Pharmaceuticals Inc. 1.95 1.24 0.84 1.29 1.38
Cash Ratio, Sector
Pharmaceuticals & Biotechnology 0.87 1.03 1.29 1.08 1.21
Cash Ratio, Industry
Health Care 0.73 0.90 1.03 0.94 1.07

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).

2018 Calculations

1 Cash ratio = Total cash assets ÷ Current liabilities
= 8,086,400 ÷ 11,888,100 = 0.68

Ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Eli Lilly & Co.’s cash ratio improved from 2016 to 2017 and from 2017 to 2018.